18F-fluciclovine
18F-fluciclovine 是目前在国外临床研究中出现的一款新药或疗法，主要研究方向为Multiple Myeloma、Newly Diagnosed Multiple Myeloma (NDMM)、Relapsed and/or Refractory Multiple Myeloma (RRMM)。下面汇总了它当前在全球正在招募患者的研究，以及中国患者可以走的申请途径。
19 项
全球在招研究
4 项
已进入 III/IV 期
14 个
开展国家和地区
暂未检索到
中国境内设点
药品与企业信息
研发企业
- National Cancer Institute (NCI)
- Fundacio Puigvert
- ECOG-ACRIN Cancer Research Group
- Oslo University Hospital
- Technical University of Munich
- Blue Earth Diagnostics
- Children's Hospital of Philadelphia
- Baptist Health South Florida
汇总自相关试验登记的主要申办方；研究机构申办时会显示相应机构名称。
生产企业
公开药品批准资料或正式说明书暂未提供明确的生产企业信息。
研发企业与生产企业可能不是同一家。研究阶段药品可能尚未公布生产企业；生产企业仅取自美国上市原研药说明书所列企业（不含仿制药），不作推测；仅在其他国家上市的药品暂无法显示。
主要开展国家和地区
比利时、法国、德国、意大利、荷兰、Poland、西班牙、瑞典、美国、挪威、澳大利亚、加拿大
正在招募患者的 18F-fluciclovine 研究
European Registry of Next Generation Imaging in Advanced Prostate Cancer
不适用招募中比利时法国德国意大利NCT06866782Identifying Findings on Brain Scans That Could Help Make Better Predictions About Brain Cancer Progression, The GABLE Trial
II 期招募中美国NCT06319027Fluciclovine PET/CT in Multiple Myeloma Patients
不适用招募中挪威NCT03966443A Prospective, Bicentric Evaluation of Fluciclovine PET-imaging in Patients with Prior Negative or Inconclusive PSMA-ligand PET
不适用招募中德国NCT06859203Treating Prostate Cancer That Has Come Back After Surgery With Apalutamide and Targeted Radiation Based on PET Imaging
III 期招募中美国NCT04423211A Study Using Nivolumab, in Combination With Chemotherapy Drugs to Treat Nasopharyngeal Carcinoma (NPC)
II 期招募中美国澳大利亚加拿大新西兰NCT06064097Impact of Fluciclovine (18F) PET (Positron Emission Tomography) on the Management of Prostate Cancer Following Negative or Equivocal PSMA (Prostate-Specific Membrane Antigen) PET Imaging at the Time of Biochemical Recurrence
IV 期招募中美国NCT07569926Evaluation of 18F-Fluciclovine Positron Emission Tomography - Magnetic Resonance Imaging (PET-MRI) in LGG
早期 I 期招募中美国NCT0555555018F-Fluciclovine PET Amino Acid Evaluation of Brain Metastasis Treated With Stereotactic Radiosurgery
I 期招募中美国NCT0604809418F-Fluciclovine PET/CT in Multiple Myeloma
II 期招募中美国NCT0610383818F-Fluciclovine PET-MRI in High-grade Glioma
早期 I 期招募中美国NCT05553041Multitracer [18F]Fluciclovine and 18F-FDG PET, and Advanced MRI for Metabolic Profiling of Glioblastoma
早期 I 期招募中美国NCT06613841Feasibility of 18F-Fluciclovine PET/CT to Identify Brain Metastasis
早期 I 期招募中美国NCT06055790Assess Use of 18F-Fluciclovine for Patients With Large Brain Metastases Treated With Staged Stereotactic Radiosurgery
I 期招募中美国NCT0468904818F-FLUC PET/MR in Patients With Brain Mets
III 期招募中美国NCT06159335Characterization of 18F-Fluciclovine PET Amino Acid Radiotracer in Resected Brain Metastasis
II 期招募中美国NCT05554302Pilot Study for Detection of PSMA-Low CRPC-NE Tumors With Fluciclovine PET/CT
I 期招募中美国NCT06062745Prostate Specific Membrane Antigen (PSMA) or (FACBC) PET/CT Site-Directed Therapy for Treatment of Prostate Cancer, Flu-BLAST-PC Study
II 期招募中美国NCT0417543118F-Fluciclovine PET/CT Impact on Predicting Clinical Outcome of 177Lu-PSMA-617 Therapy in Patients With Prostate Cancer
IV 期招募中美国NCT06706921
中国患者怎么争取用上这款药
目前境内暂未检索到设点，下面几条途径是更现实的选择，每条都有详细的中文做法。
查看完整申请指南同类方向的其他在研新药
本页信息整理自 ClinicalTrials.gov 公开登记数据，仅供参考，不构成医疗建议；是否适合使用该药物，请以专业医生和研究团队的意见为准。